シンバイオ製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/12/17 | 1,180 | 1,205 | 1,164 | 1,181 | -19 | -1.6% | 1,248,500 |
2021/12/16 | 1,198 | 1,210 | 1,168 | 1,200 | +30 | +2.6% | 1,309,700 |
2021/12/15 | 1,134 | 1,189 | 1,133 | 1,170 | +22 | +1.9% | 1,150,000 |
2021/12/14 | 1,143 | 1,183 | 1,139 | 1,148 | -11 | -0.9% | 979,400 |
2021/12/13 | 1,190 | 1,194 | 1,138 | 1,159 | -21 | -1.8% | 1,434,400 |
2021/12/10 | 1,196 | 1,213 | 1,166 | 1,180 | -20 | -1.7% | 1,684,300 |
2021/12/09 | 1,261 | 1,285 | 1,194 | 1,200 | -91 | -7% | 3,136,400 |
2021/12/08 | 1,206 | 1,299 | 1,200 | 1,291 | +89 | +7.4% | 2,820,400 |
2021/12/07 | 1,197 | 1,227 | 1,170 | 1,202 | +61 | +5.3% | 2,181,100 |
2021/12/06 | 1,200 | 1,210 | 1,131 | 1,141 | -95 | -7.7% | 2,476,500 |
2021/12/03 | 1,190 | 1,273 | 1,171 | 1,236 | +60 | +5.1% | 3,976,300 |
2021/12/02 | 1,235 | 1,253 | 1,159 | 1,176 | -67 | -5.4% | 2,585,000 |
2021/12/01 | 1,320 | 1,340 | 1,187 | 1,243 | -61 | -4.7% | 3,230,000 |
2021/11/30 | 1,416 | 1,440 | 1,292 | 1,304 | -94 | -6.7% | 3,455,700 |
2021/11/29 | 1,403 | 1,467 | 1,380 | 1,398 | -79 | -5.3% | 3,607,700 |
2021/11/26 | 1,585 | 1,608 | 1,445 | 1,477 | -87 | -5.6% | 3,319,100 |
2021/11/25 | 1,758 | 1,758 | 1,460 | 1,564 | -193 | -11% | 6,600,600 |
2021/11/24 | 1,782 | 1,852 | 1,755 | 1,757 | -24 | -1.3% | 5,375,200 |
2021/11/22 | 1,750 | 1,888 | 1,718 | 1,781 | +7 | +0.4% | 8,743,700 |
2021/11/19 | 1,789 | 1,813 | 1,724 | 1,774 | -26 | -1.4% | 4,795,700 |
2021/11/18 | 1,791 | 1,867 | 1,701 | 1,800 | +99 | +5.8% | 14,659,900 |
2021/11/17 | 1,429 | 1,701 | 1,418 | 1,701 | +300 | +21.4% | 12,563,100 |
2021/11/16 | 1,490 | 1,610 | 1,362 | 1,401 | +54 | +4% | 15,079,300 |
2021/11/15 | 1,347 | 1,347 | 1,347 | 1,347 | +300 | +28.7% | 317,600 |
2021/11/12 | 1,047 | 1,047 | 1,047 | 1,047 | +150 | +16.7% | 163,700 |
2021/11/11 | 931 | 934 | 890 | 897 | -25 | -2.7% | 1,782,200 |
2021/11/10 | 930 | 952 | 913 | 922 | -8 | -0.9% | 1,015,400 |
2021/11/09 | 943 | 963 | 925 | 930 | -15 | -1.6% | 1,320,200 |
2021/11/08 | 992 | 1,002 | 934 | 945 | -54 | -5.4% | 2,122,400 |
2021/11/05 | 1,039 | 1,039 | 990 | 999 | -40 | -3.8% | 1,545,200 |
2021/11/04 | 1,039 | 1,065 | 1,025 | 1,039 | +14 | +1.4% | 807,500 |
2021/11/02 | 1,038 | 1,051 | 1,020 | 1,025 | ±0 | ±0% | 731,700 |
2021/11/01 | 1,070 | 1,080 | 1,018 | 1,025 | -43 | -4% | 1,197,800 |
2021/10/29 | 1,099 | 1,109 | 1,064 | 1,068 | -22 | -2% | 1,346,600 |
2021/10/28 | 1,081 | 1,107 | 1,072 | 1,090 | -1 | -0.1% | 1,219,600 |
2021/10/27 | 1,065 | 1,114 | 1,047 | 1,091 | +22 | +2.1% | 2,332,000 |
2021/10/26 | 1,002 | 1,085 | 999 | 1,069 | +67 | +6.7% | 2,767,900 |
2021/10/25 | 1,015 | 1,032 | 976 | 1,002 | +26 | +2.7% | 1,978,500 |
2021/10/22 | 965 | 994 | 958 | 976 | +12 | +1.2% | 1,059,600 |
2021/10/21 | 1,013 | 1,032 | 961 | 964 | -56 | -5.5% | 2,177,700 |
2021/10/20 | 1,030 | 1,033 | 1,008 | 1,020 | -7 | -0.7% | 703,000 |
2021/10/19 | 1,009 | 1,034 | 1,003 | 1,027 | +14 | +1.4% | 751,200 |
2021/10/18 | 1,039 | 1,060 | 1,006 | 1,013 | -26 | -2.5% | 1,279,600 |
2021/10/15 | 993 | 1,047 | 993 | 1,039 | +45 | +4.5% | 2,035,700 |
2021/10/14 | 1,005 | 1,013 | 983 | 994 | -15 | -1.5% | 1,058,500 |
2021/10/13 | 1,002 | 1,028 | 995 | 1,009 | +1 | +0.1% | 703,300 |
2021/10/12 | 1,047 | 1,072 | 1,001 | 1,008 | -14 | -1.4% | 1,639,600 |
2021/10/11 | 1,001 | 1,024 | 996 | 1,022 | +21 | +2.1% | 796,100 |
2021/10/08 | 992 | 1,009 | 982 | 1,001 | +24 | +2.5% | 992,700 |
2021/10/07 | 973 | 1,011 | 967 | 977 | +4 | +0.4% | 1,586,500 |
901~
950
件表示中 / 3387件
類似銘柄と比較する
現在ご覧いただいている「シンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
シンバイオ | 15,100円 | -42.9% | - | 0.00% | - | 3.64倍 |
|
導入で新薬開発・製品化。抗がん剤「トレアキシン」国内販売。抗ウイルス薬BCVの開発に注力 |
ノイルイミューン | 18,900円 | -28.6% | - | 0.00% | - | 1.90倍 |
|
独自技術用いたCAR-T細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
ケイファーマ | 69,500円 | - | - | 0.00% | - | 4.45倍 |
|
慶応大学発ベンチャー。iPS細胞による再生医療と創薬の2本柱。中枢神経系が得意領域 |
DELTA-P | 62,800円 | - | - | 0.00% | - | 26.32倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
ティムス | 15,700円 | - | - | 0.00% | - | 2.56倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補を中国CORXEL社に導出 |
市場注目の銘柄
チャート関連のコラム